Extension Study of Protocol RC-001- Safety and Efficacy of Adult Adipose-Derived Stem Cell Injection into Partial Thickness Rotator Cuff Tears. Purpose is to investigate the Long- term safety and efficacy of autologous stem cells in patients with partial thickness rotator cuff tears versus a steroid treatment.
Age range
30 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Long term Safety as indicated through adverse event rate between ADSC and TAU arms
Timeframe: at 24 months
Long term Safety as indicated through adverse event rate between ADSC and TAU arms
Timeframe: at 36 months
Long term efficacy of pain and function through Short Form-36 Shoulder Score health questionnaires
Timeframe: at 24 months
Long term efficacy of pain and function through Short Form-36 Shoulder Score health questionnaires
Timeframe: at 36 months
Long term efficacy of pain and function through ASES Shoulder Score health questionnaires
Timeframe: at 24 months
Long term efficacy of pain and function through ASES Shoulder Score health questionnaires
Timeframe: at 36 months